Drug ID: | NPD6995 |
Drug Name: | Cep-5214 |
Molecular Formula: | C28H28N2O3 |
Canonical SMILES: | OCCCn1c2c3Cc4c(c3c3c(c2c2c1ccc(c2)COC(C)C)CNC3=O)cccc4 |
Standard InCHI: | InChI=1S/C28H28N2O3/c1-16(2)33-15-17-8-9-23-20(12-17)25-22-14-29-28(32)26(22)24-19-7-4-3-6-18(19)13-21(24)27(25)30(23)10-5-11-31/h3-4,6-9,12,16,31H,5,10-11,13-15H2,1-2H3,(H,29,32) |
Standard InCHIKey: | MLIFNJABMANKEU-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB013086 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 440.21 |
ALogP | -0.9692 |
MLogP | 3.99 |
XLogP | 5.188 |
HDA | 5 |
HBD | 2 |
Rotatable Bonds | 9 |
TPSA | 63.49 |
RO5 Violation | 1 |